All Releases
 |
Questcor Reports Solid Fourth Quarter Results
Mar 1, 2010
|
5.1 KB |
|
| |
http://finance.yahoo.com/news/Questcor-Reports-Solid-Fourth-prnews-1906025805.html?x=0
...
|
|
Questcor Announces Fourth Quarter 2009 Earnings Release Date and Conference Call
Feb 11, 2010
|
6.5 KB |
|
| |
UNION CITY, Calif., Feb. 11, 2010 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) today announced that it will release financial results for the fourth quarter ended December 31, 2009 on Monday, March 1, 2010 after the market close. The Company will host a conference call and webcast on Monday, March 1, 2010 at 5:00 p.m. Eastern / ...
|
|
Questcor Appoints Jason Zielonka, M.D. Chief Medical Officer
Feb 4, 2010
|
14.9 KB |
|
| |
UNION CITY, Calif., Feb. 4, 2010 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) announced today that Jason Zielonka, M.D., (61), has been appointed to the position of Chief Medical Officer. Dr. Zielonka has accepted the Company's offer to become Chief Medical Officer effective February 16, 2010 and will report directly to Don M. ...
|
|
FDA Accepts for Review Questcor's Filing of Its Supplemental New Drug Application for H.P. Acthar® Gel for Treatment of Infantile Spasms
Dec 24, 2009
|
11.0 KB |
|
| |
UNION CITY, Calif., Dec. 24, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) today announced the U.S. Food & Drug Administration (FDA) now considers that Questcor has provided a complete response to all prior action letters for its supplemental New Drug Application (sNDA) to market H.P. Acthar®...
|
|
Louis Silverman Appointed to Questcor Board of Directors
Dec 11, 2009
|
11.3 KB |
|
| |
UNION CITY, Calif., Dec. 11, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) announced today that Louis E. Silverman has been appointed to its Board of Directors. Mr. Silverman, 51 is currently Chief Executive Officer of privately-held Marina Medical Billing Service Inc. based in Cerritos, CA, , a company focused on providing ...
|
|
Questcor Announces Third Quarter 2009 Results
Nov 2, 2009
|
28.8 KB |
|
| |
UNION CITY, Calif., Nov. 2, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) today reported financial results for its third quarter ended September 30, 2009. As previously reported on September 21, 2009, Questcor's financial results w...
|
|
Questcor to Present at the 20th Annual Oppenheimer Healthcare Conference in New York
Oct 27, 2009
|
7.7 KB |
|
| |
UNION CITY, Calif., Oct. 27, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) announced today that it will present at the 20th Annual Oppenheimer Healthcare Conference on Wednesday, November 4, 2009 at The Waldorf-Astoria Hotel ...
|
|
Questcor Issues Corrected Dial-in Numbers for November 2nd Quarterly Conference Call
Oct 26, 2009
|
8.2 KB |
|
| |
UNION CITY, Calif., Oct. 26, 2009 (GLOBE NEWSWIRE) -- In the news release, "Questcor Announces Third Quarter 2009 Earnings Release Date and Conference Call," issued on October 23, 2009 by Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR), the conference call dial-in numbers ...
|
|
Questcor Announces Third Quarter 2009 Earnings Release Date and Conference Call
Oct 23, 2009
|
8.0 KB |
|
| |
UNION CITY, Calif., Oct. 23, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) today announced that it will release financial results for the third quarter ended September 30, 2009 on Monday, November 2, 2009 after the market close. Th...
|
|
Questcor Implements Two Corporate Governance Actions
Oct 22, 2009
|
7.9 KB |
|
| |
UNION CITY, Calif., Oct. 22, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) today announced that its Board of Directors has unanimously approved two corporate governance matters to provide Questcor's shareholders more say with respect to proposals to acquire the...
|
|
Questcor Expands Management Team
Oct 22, 2009
|
11.5 KB |
|
| |
UNION CITY, Calif., Oct 22, 2009 (GlobeNewswire via COMTEX) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) announced today that David Young, Pharm.D., Ph.D., currently a member of Questcor's Board of Directors, has been appointed to the newly created position of Chief Scientific Officer, and Sian E. Bigora, Pharm.D. has been appointed to the newly...
|
|
Questcor Resubmits Supplemental New Drug Application to FDA for H.P. Acthar® Gel for Treatment of Infantile Spasms
Oct 15, 2009
|
11.8 KB |
|
| |
UNION CITY, Calif., Oct. 15, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) announced that it has resubmitted its filing to the U.S. Food & Drug Administration (FDA) for its supplemental New Drug Application (sNDA) seeking approval to market H.P. ...
|
|
Gregg Lapointe Appointed to Questcor Board of Directors
Oct 12, 2009
|
12.1 KB |
|
| |
UNION CITY, Calif., Oct. 12, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. announced today that Gregg A. Lapointe has been appointed to its Board of Directors. Mr. Lapointe, 50, is currently Chief Executive Officer of privately-held Sigma-Tau Pharmaceut...
|
|
Questcor to Present At the 2009 Maxim Group Growth Conference in New York
Sep 25, 2009
|
7.1 KB |
|
| |
UNION CITY, Calif., Sept. 25, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) announced today that it will present at the Maxim Group Growth Conference on Tuesday, September 29, 2009 at the Grand Hyatt Hotel in New York City. Steve Cartt, Executive Vice President of Corporate Development, will discuss the Company's business...
|
|
Questcor Provides Update on Corporate Developments and Third Quarter Sales Trends
Sep 21, 2009
|
13.7 KB |
|
| |
UNION CITY, Calif., Sept. 21, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) today provided an update on corporate developments and sales trends for the third quarter ending September 30, 2009 in advance of management presentations at two investor conferences in the next ten days.
Questcor has notified the U.S. Fo...
|
|
Questcor to Present At the 2009 UBS Global Life Sciences Conference in New York
Sep 18, 2009
|
7.1 KB |
|
| |
UNION CITY, Calif., Sept. 18, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) announced today that it will present at the UBS Global Life Sciences Conference on Tuesday, September 22, 2008 at the Grand Hyatt Hotel in New York City. Don M. Bailey, President and Chief Executive Officer, will discuss the Company's business str...
|
|
Questcor Pharmaceuticals to Present At BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York
Aug 3, 2009
|
6.8 KB |
|
| |
UNION CITY, Calif., Aug. 3, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) today announced that Don M. Bailey, President and Chief Executive Officer, will present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference at the Millennium Broadway Hotel on Wednesday, August 5th at 8:00 am Eastern Time.
...
|
|
Questcor Reports Second Quarter 2009 Results
Jul 29, 2009
|
18.5 KB |
|
| |
UNION CITY, Calif., July 29, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) today reported financial results for its second quarter ended June 30, 2009. Net sales totaled $25.3 million for the three months ended June 30, 2009, compared with $24.9 million for the same period of 2008. Net income for the second quarter of 200...
|
|
Questcor and Child Neurology Foundation Announce Creation of Infantile Spasms Awareness Week
Jul 27, 2009
|
9.5 KB |
|
| |
UNION CITY, Calif., July 27 /PRNewswire-FirstCall/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that it has joined with the Child Neurology Foundation (CNF) to officially support the creation of Infantile Spasms (IS) Awareness Week. The first annual IS Awareness Week will take place the week of October 11-17, 2009, in conjunc...
|
|
Questcor Announces Second Quarter 2009 Earnings Release Date and Conference Call
Jul 20, 2009
|
7.8 KB |
|
| |
UNION CITY, Calif., Jul 20, 2009 (GlobeNewswire via COMTEX) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) today announced that it will release financial results for the second quarter ended June 30, 2009 on Wednesday, July 29, 2009 after the market close. The Company will host a conference call and webcast on Wednesday, July 29, 2009 at 4:30 p...
|
|
|
